Thurston Springer Miller Herd & Titak’s Edwards Lifesciences EW Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36K	Hold	15	–	–	﹤0.01%	1140
2026 Q1	$1.2K	Hold	15	–	–	﹤0.01%	1235
2025 Q4	$1.28K	Buy	+15	New	+$1.23K	﹤0.01%	1268
2025 Q3	–	Sell	-64	Closed	-$5K	–	802
2025 Q2	$5K	Buy	64 +2	+3%	+$149	﹤0.01%	1284
2025 Q1	$4.49K	Buy	62 +20	+48%	+$1.43K	﹤0.01%	1301
2024 Q4	$3.11K	Sell	42 -64	-60%	-$4.48K	﹤0.01%	1080
2024 Q3	$6.99K	Sell	106 -8	-7%	-$581	﹤0.01%	1130
2024 Q2	$10.5K	Buy	+114	New	+$10.1K	﹤0.01%	981

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's EW Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Edwards Lifesciences (EW) position steady in Q2 2026 at 15 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Thurston Springer Miller Herd & Titak first reported a position in EW in Q2 2024 and has held it in 8 quarters since. The position peaked at $10.5K in Q2 2024. 458 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Thurston Springer Miller Herd & Titak held 15 shares of Edwards Lifesciences worth $1.36K as of Q2 2026.
Thurston Springer Miller Herd & Titak left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1140 holding.
Thurston Springer Miller Herd & Titak first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 8 quarters since.
Thurston Springer Miller Herd & Titak's Edwards Lifesciences position peaked at $10.5K in Q2 2024.
458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.